Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Yael L. Maxwell

May 03, 2024

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

Prehospital Troponin Testing With EMS Input Could Save a Lot of Money

Michael O'Riordan

February 07, 2023

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Conference News AHA 2021

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Shelley Wood

November 15, 2021

News Conference News ACC 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Michael O'Riordan

May 17, 2021

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2019

Shelley Wood

August 30, 2019

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

News Daily News

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Caitlin E. Cox

June 13, 2019

News Conference News ACC 2019

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

Yael L. Maxwell

March 18, 2019

News Conference News EuroPCR 2017

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

Shelley Wood

June 02, 2017

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Daily News

After GRAVITAS: Is There a Future for Functional Platelet Testing?

July 18, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

Advertisement

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

October 2023 News Roundup

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Prehospital Troponin Testing With EMS Input Could Save a Lot of Money

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

TCTMD’s Top 10 Most Popular Stories for August 2019

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

ESC Congress 2011: Drugs, Devices Work Together

After GRAVITAS: Is There a Future for Functional Platelet Testing?

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content